Products

At MedImmune, we seek to develop innovative, high-value products in which we have significant interest, both independently and in collaboration with our partners. By creating cutting-edge biological products, we're improving health, enhancing lives and helping to make a world of difference.

Ethyol®

Synagis^® (palivizumab) is the only monoclonal antibody approved by the U.S. Food and Drug Administration (FDA) to help prevent an infectious disease. Synagis is indicated for the prevention of serious lower respiratory tract disease caused by RSV in children at high risk of RSV disease.

MedImmune is dedicated to assisting patients with access to support and resources. To learn more, click here.

To learn more about Synagis, click here for Important Safety & Prescribing Information.

Approved Synagis Distribution Network Members

Approved Physician Purchase Channel Distributors

Wholesale Accounts
AmerisourceBergen
Cardinal
H.D. Smith
McKesson
Morris Dickson

FluMist^® (Influenza Vaccine Live, Intranasal) is the first and only nasal spray flu vaccine approved in the United States to help prevent influenza and is indicated for the active immunization of eligible individuals 2 to 49 years of age against influenza disease caused by influenza virus subtypes A and B contained in the vaccine.

To learn more about FluMist, click here for Important Safety & Prescribing Information.

Ethyol^® (amifostine) is a selective cytoprotective agent used to help reduce certain toxicities associated with cancer chemotherapy and radiotherapy.

To learn more about Ethyol, click here for Important Safety & Prescribing Information.